-Ursula Dietrich Researcher Activity Profile

Research Author Detailed Information 

Ursula Dietrich Publication Rate By Year

Ursula Dietrich has published 1 paper(s) in 1949, 1 paper(s) in 2001, 1 paper(s) in 2002, 5 paper(s) in 2007, 7 paper(s) in 2008, for a total of 15 research publications in total.

Ursula U Dietrich Author Information

LAST NAME: dietrich

FIRST NAME: Ursula

INITIALS: u

AFFILIATION:

Papers

Ursula Dietrich's Publication Record

1. Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures. Year Published: 2007
2. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry. Year Published: 2007
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt am Main, Germany.
3. Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures. Year Published: 2007
4. [Not Available.] Year Published: 1949
5. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry. Year Published: 2007
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt am Main, Germany.
6. Genetic and Biological Characterization of Recombinant HIV Type 1 with Env Derived from Long-Term Nonprogressor (LTNP) Viruses. Year Published: 2008
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
7. Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses. Year Published: 2008
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
8. Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures. Year Published: 2007
9. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1. Year Published: 2008
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
10. Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses. Year Published: 2008
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
11. Targeting the Viral Nucleocapsid Protein in Anti-HIV-1 Therapy. Year Published: 2008
12. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1. Year Published: 2008
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
13. Aneurysmal rupture during embolization with Guglielmi detachable coils: causes, management, and outcome. Year Published: 2001
Department of Neuroradiology, University of Essen Medical School, Germany.
14. Endovascular treatment of unruptured intracranial aneurysms. Year Published: 2002
Department of Neuroradiology, University Hospital of Essen, Essen, Germany.
15. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy. Year Published: 2008